Loading...
•
Sep 30, 2025
Teladoc Q3 2025 Earnings Report
Teladoc Health reported a decrease in revenue and adjusted EBITDA, alongside an increased net loss for the third quarter of 2025.
Key Takeaways
Teladoc Health experienced a challenging third quarter in 2025, with consolidated revenues decreasing by 2% to $626.4 million and adjusted EBITDA falling by 16% to $69.9 million. The company reported a net loss of $49.5 million, or $0.28 per share, which included a non-cash goodwill impairment charge.
Consolidated revenue decreased by 2% to $626.4 million in Q3 2025 compared to Q3 2024.
Net loss for Q3 2025 was $49.5 million, or $0.28 per share, an increase from $33.3 million in Q3 2024.
Adjusted EBITDA decreased by 16% to $69.9 million in Q3 2025.
Integrated Care segment revenue increased by 2% while BetterHelp segment revenue decreased by 8%.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The financial outlook is based on current market conditions and expectations, with a focus on advancing strategic priorities and growth initiatives.
Positive Outlook
- Continued focus on advancing strategic priorities.
- Growth initiatives to drive greater value and impact within the Integrated Care segment.
- Ongoing rollout of insurance acceptance in BetterHelp.
- Commitment to serving clients and members.
- Consistent execution in delivering consolidated revenues and adjusted EBITDA within guidance ranges.
Challenges Ahead
- No specific negative forward guidance points were explicitly stated in the provided text.
- The company did not provide specific numerical guidance for future periods in this report.
- General market uncertainties and competitive pressures could impact future performance.
- Potential for further goodwill impairment charges.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...